Sei Investments Co. cut its stake in STERIS PLC (NYSE:STE) by 7.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,220 shares of the medical equipment provider’s stock after selling 9,394 shares during the period. Sei Investments Co.’s holdings in STERIS PLC were worth $9,064,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. raised its position in shares of STERIS PLC by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock valued at $9,171,000 after buying an additional 48,188 shares during the last quarter. Sit Investment Associates Inc. raised its position in shares of STERIS PLC by 1.4% in the first quarter. Sit Investment Associates Inc. now owns 35,000 shares of the medical equipment provider’s stock valued at $2,431,000 after buying an additional 475 shares during the last quarter. Speece Thorson Capital Group Inc. raised its position in shares of STERIS PLC by 2.8% in the first quarter. Speece Thorson Capital Group Inc. now owns 155,644 shares of the medical equipment provider’s stock valued at $10,811,000 after buying an additional 4,278 shares during the last quarter. BTIM Corp. raised its position in shares of STERIS PLC by 2.7% in the first quarter. BTIM Corp. now owns 93,799 shares of the medical equipment provider’s stock valued at $6,515,000 after buying an additional 2,436 shares during the last quarter. Finally, NBW Capital LLC raised its position in shares of STERIS PLC by 24.0% in the first quarter. NBW Capital LLC now owns 47,312 shares of the medical equipment provider’s stock valued at $3,286,000 after buying an additional 9,170 shares during the last quarter. Institutional investors and hedge funds own 91.80% of the company’s stock.

Shares of STERIS PLC (NYSE STE) opened at 84.94 on Friday. STERIS PLC has a 52 week low of $63.80 and a 52 week high of $87.49. The stock has a market capitalization of $7.24 billion, a P/E ratio of 60.76 and a beta of 1.33. The stock has a 50 day moving average price of $82.58 and a 200 day moving average price of $75.07.

STERIS PLC (NYSE:STE) last issued its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. During the same period in the previous year, the firm posted $0.79 EPS. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. On average, equities research analysts expect that STERIS PLC will post $4.06 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Investors of record on Tuesday, August 29th will be given a $0.31 dividend. The ex-dividend date of this dividend is Friday, August 25th. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 1.46%. STERIS PLC’s dividend payout ratio is 80.00%.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/sei-investments-co-sells-9394-shares-of-steris-plc-nyseste/1476961.html.

Several brokerages have issued reports on STE. Raymond James Financial, Inc. increased their price target on STERIS PLC from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday. Zacks Investment Research raised STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a research note on Tuesday, July 11th. BidaskClub downgraded STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Wellington Shields downgraded STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Finally, KeyCorp raised STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective for the company in a research note on Wednesday, May 3rd. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $86.75.

In related news, VP Sudhir K. Pahwa sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $79.07, for a total value of $237,210.00. Following the transaction, the vice president now directly owns 22,047 shares of the company’s stock, valued at approximately $1,743,256.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Sudhir K. Pahwa sold 800 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $77.28, for a total value of $61,824.00. The disclosure for this sale can be found here. Insiders sold a total of 33,084 shares of company stock worth $2,668,633 over the last ninety days. 2.55% of the stock is currently owned by insiders.

STERIS PLC Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).

Institutional Ownership by Quarter for STERIS PLC (NYSE:STE)

Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.